Enhancing electronic health record measurement of depression severity and suicide ideation: A distributed ambulatory research in therapeutics network (DARTNet) study

Journal of the American Board of Family Medicine

Volumn 25, Issue 5, 2012, Pages 582-593

  Valuck, Robert J ^a,b   Anderson, Heather O ^a,b   Libby, Anne M ^a,b   Brandt, Elias ^c   Bryan, Cathy ^d   Allen, Richard R ^e   Staton, Elizabeth W ^b   West, David R ^f   Pace, Wilson D ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Transportation Research Institute   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Dba CINA   (United States)

^e Peak Statistical Services   (United States)

^f NONE

Author keywords

Clinical epidemiology; Depression; Practice based research; Practice based research networks; Suicide

Indexed keywords

AMFEBUTAMONE; ANXIOLYTIC AGENT; NARCOTIC ANALGESIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

9 ITEM PATIENT HEALTH QUESTIONNAIRE; ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER NETWORK; DEPRESSION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL INFORMATION SYSTEM; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEASUREMENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SUICIDAL IDEATION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUICIDAL IDEATION; UNITED STATES; YOUNG ADULT;

EID: 84866153752     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2012.05.110053     Document Type: Article

References (22)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
2. Murray CJL, Lopez AD, eds. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. The Global Burden of Disease and Injury Series, no. 1. Cambridge, MA: Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Harvard University Press; 1996.
3. Nease DE Jr, Volk RJ, Cass AR. Does the severity of mood and anxiety symptoms predict health care utilization? J Fam Pract 1999;48:769-77.
4. Blom MB, Spinhoven P, Hoffman T, et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord 2007;104:119-26.
5. Thase ME, Simons AD, Cahalane J, McGeary J, Harden T. Severity of depression and response to cognitive behavior therapy. Am J Psychiatry 1991; 148:784-9.
6. Kroenke K, Spitzer RL. The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann 2002;32:509-21.
7. Goldsmith S, Pellmar T, Kleinman A, Bunney W, eds. Reducing Suicide: A National Imperative. Washington, DC: Institute of Medicine National Academies Press; 2002.
8. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997;170:205-28.
9. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
10. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34:73-82.
11. O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009;151:793-803.
12. Agency for Healthcare Research and Quality. Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. In: Effective Health Care. Pub. No. 07-EHC007-1. Rockville, MD: AHRQ; 2007.
13. Pace W, et al. Distributed Ambulatory Research in Therapeutics Network (DARTNet): summary report. July 2009, Prepared by University of Colorado DEcIDE Center under Contract No. HHSA 29020050037I-TO2. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http:// effectivehealthcare.ahrq. gov/ehc/products/53/151/ 2009-0728DEcIDE-DARTNet.pdf. Accessed December 4, 2010.
14. Pace WD, Cifuentes M, Valuck RJ, et al. An electronic practice-based network for observational comparative effectiveness research. Ann Intern Med 2009;151:338-40.
15. Agency for Health Care Research and Quality. Distributed Ambulatory Research in Therapeutics Network-(DARTNet): Summary Report, Appendix A, pages A4-A8. Available at: http://effectivehealthcare.ahrq. gov/ehc/products/53/152/ 2009-0728DEcIDE-DARTNet-Appendices.pdf. Accessed December 4, 2010.
16. National Committee for Quality Assurance. HEDIS volume 2: technical specifications. Washington, D.C.: National Committee for Quality Assurance; 2004.
17. Scholle SH. NCQA behavioral health measurement efforts. J Managed Care Pharm 2005;11:S9-S11.
18. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884-91.
19. Valuck R, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after the FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 2007;164:1198-205.
20. Gaynes BN, Rush AJ, Trivedi MH, et al. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med 2007;5:126-34.
21. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
22. Ormel J, Koeter MW, van den Brink W, et al. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 1991;48:700-6.